Table 2.
2-way ANOVA P value | ||||||
---|---|---|---|---|---|---|
| ||||||
Parameters | Groups | Men | Women | Sex-gender | Smoke | Interaction |
Glycaemia (mg dl-1) | Non-S | 1.1 ± 0.2 | 1.5 ± 0.3b1,d2 | < 0.001 | ns | 0.033 |
S | 1.1 ± 0.2c2 | 1.3 ± 0.3 | ||||
TChol (mg dl-1) | Non-S | 2.5 ± 0.5d3 | 3.4 ± 0.6 | < 0.001 | ns | ns |
S | 2.4 ± 0.5c3 | 3.4 ± 0.5 | ||||
LDL (mg dl-1) | Non-S | 1.5 ± 0.4d3 | 2.0 ± 0.4 | < 0.001 | ns | ns |
S | 1.3 ± 0.4c3 | 2.0 ± 0.4 | ||||
HDL (mg dl-1) | Non-S | 0.7 ± 0.2d3 | 1.1 ± 0.3 | < 0.001 | ns | ns |
S | 0.8 ± 0.2c3 | 1.1 ± 0.2 | ||||
HDL/LDL | Non-S | 0.007 ± 0.004a2,d3 | 0.01 ± 0.004 | < 0.001 | ns | 0.014 |
S | 0.01 ± 0.005 | 0.01 ± 0.003 | ||||
TG (mg dl-1) | Non-S | 1.2 ± 0.5 | 1.3 ± 0.4b2 | ns | 0.023 | ns |
S | 1.3 ± 0.8c1 | 1.6 ± 0.8 | ||||
Cr (mg ml-1) | Non-S | 0.01 ± 0.001 | 0.01 ± 0.002 | ns | ns | ns |
S | 0.01 ± 0.003 | 0.01 ± 0.001 | ||||
Urea (mg dl-1) | Non-S | 0.49 ± 0.13 | 0.55 ± 0.18 | ns | ns | ns |
S | 0.48 ± 0.14 | 0.51 ± 0.15 | ||||
Uric Acid (mg dl-1) | Non-S | 0.07 ± 0.01 | 0.07 ± 0.02 | ns | ns | ns |
S | 0.07 ± 0.02 | 0.07 ± 0.02 | ||||
AST (U l-1) | Non-S | 0.38 ± 0.15 | 0.37 ± 0.11 | ns | ns | ns |
S | 0.36 ± 0.17 | 0.36 ± 0.10 | ||||
ALT (U l-1) | Non-S | 0.47 ± 0.25a1,d3 | 0.33 ± 0.15 | 0.027 | ns | 0.037 |
S | 0.37 ± 0.17 | 0.36 ± 0.19 | ||||
γ-GT (U l-1) | Non-S | 0.35 ± 0.15 | 0.29 ± 0.09 | ns | 0.048 | ns |
S | 0.37 ± 0.18 | 0.35 ± 0.26 | ||||
Bilirubin (mg dl-1) | Non-S | 0.01 ± 0.006 | 0.01 ± 0.009 | ns | ns | ns |
S | 0.01 ± 0.006 | 0.01 ± 0.008 | ||||
Alkaline Phosphatase (U l-1) | Non-S | 0.96 ± 0.27d2 | 1.11 ± 0.36 | < 0.001 | ns | ns |
S | 0.93 ± 0.26c2 | 1.13 ± 0.27 | ||||
Na+ (mEq l-1) | Non-S | 1.94 ± 0.26d3 | 2.65 ± 0.36 | < 0.001 | ns | ns |
S | 2.09 ± 0.32c3 | 2.55 ± 0.38 | ||||
K+ (mEq l-1) | Non-S | 0.06 ± 0.009d3 | 0.08 ± 0.01 | < 0.001 | ns | ns |
S | 0.06 ± 0.009c3 | 0.07 ± 0.01 | ||||
Ca2+ (mg dl-1) | Non-S | 0.13 ± 0.02d3 | 0.18 ± 0.03 | < 0.001 | ns | ns |
S | 0.14 ± 0.02c3 | 0.17 ± 0.02 | ||||
Sideremia (µg l-1) | Non-S | 1.42 ± 0.58 | 1.59 ± 0.78 | 0.04 | ns | ns |
S | 1.34 ± 0.45 | 1.64 ± 0.82 | ||||
TSH (µUI ml-1) | Non-S | 0.03 ± 0.02d2 | 0.04 ± 0.01 | 0.026 | ns | ns |
S | 0.03 ± 0.02 | 0.03 ± 0.02 | ||||
RBC (1012 l-1) | Non-S | 0.08 ± 0.01d3 | 0.09 ± 0.01 | < 0.001 | ns | ns |
S | 0.08 ± 0.02 | 0.09 ± 0.01 | ||||
Hb (g dl-1) | Non-S | 0.19 ± 0.03d3 | 0.24 ± 0.03 | < 0.001 | ns | ns |
S | 0.21 ± 0.03c2 | 0.24 ± 0.04 | ||||
Haematocrit (%) | Non-S | 0.59 ± 0.08d3 | 0.73 ± 0.11 | < 0.001 | ns | ns |
S | 0.63 ± 0.09c2 | 0.71 ± 0.11 | ||||
MCV (fl) | Non-S | 1.07 ± 0.19d3 | 1.52 ± 0.26 | < 0.001 | ns | ns |
S | 1.16 ± 0.22c3 | 1.52 ± 0.26 | ||||
WBC (109 l-1) | Non-S | 0.09 ± 0.02a1,d3 | 0.12 ± 0.03b1 | < 0.001 | < 0.001 | ns |
S | 0.11 ± 0.02c2 | 0.13 ± 0.04 | ||||
Neutrophils (103 µl-1) | Non-S | 0.05 ± 0.01a1,d3 | 0.06 ± 0.02 | < 0.001 | 0.006 | ns |
S | 0.06 ± 0.02 | 0.07 ± 0.02 | ||||
Lymphocytes (103 µl-1) | Non-S | 0.03 ± 0.009d3 | 0.04 ± 0.01b1 | < 0.001 | 0.005 | ns |
S | 0.04 ± 0.01c2 | 0.05 ± 0.02 | ||||
Monocytes (103 µl-1) | Non-S | 0.006 ± 0.002 | 0.006 ± 0.002b1 | ns | 0.005 | ns |
S | 0.007 ± 0.002 | 0.007 ± 0.002 | ||||
Eosinophils (103 µl-1) | Non-S | 0.003 ± 0.002a2 | 0.003 ± 0.002 | ns | 0.005 | ns |
S | 0.005 ± 0.008 | 0.004 ± 0.002 | ||||
Basophils (103 µl-1) | Non-S | 0.0006 ± 0.0005 | 0.0006 ± 0.0007 | ns | ns | ns |
S | 0.0009 ± 0.0008 | 0.0008 ± 0.0007 | ||||
PLT (109 l-1) | Non-S | 3.58 ± 0.89d3 | 5.17 ± 1.24 | < 0.001 | ns | ns |
S | 3.61 ± 0.92c3 | 5.59 ± 1.37 |
Data are reported as the means ± SD. P-values are reported for sex-gender and smoking effects, as well as for sex-gender x smoking interaction. For each parameter, the degree of freedom was 1. Multiple comparison analysis: a1-b1-c1-d1 for P = 0.05-0.01; a2-b2-c2-d2 for P = 0.01-0.001; a3-b3-c3-d3 for P ≤ 0.001; S = smoking; Non-S = non-smoking, ns = not significant.